Skip to content

Observational Study to Evaluate Ventral Incisional Hernia Repair Using a Biologic Mesh (Cook Biodesign)

Observational Study to Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biologic Mesh (Cook Biodesign) for Midline Fascial Closure Reinforcement

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02129140
Enrollment
30
Registered
2014-05-02
Start date
2014-04-30
Completion date
2019-05-16
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventral Incisional Hernia

Keywords

hernia repair, ventral incisional hernia, biologic mesh, hernia graft

Brief summary

The purpose of this study is to evaluate the efficacy of the Cook Biodesign mesh for the repair of complex ventral incisional hernias. Using materials to reinforce tissue defects is indicated as standard of care for this type of surgery. The Cook Biodesign mesh is currently FDA-approved for implantation to reinforce soft tissues where weakness exists, but the investigators would like to collect additional follow-up information to continue to assess the durability of the repair after placement of the hernia mesh. This follow-up would include the collection of information about complications such as infections and seromas (collections of fluid around the surgery site), as well as hernia recurrence and quality of life questionnaires. Patients who qualify to take part in this study have been diagnosed with a ventral incisional hernia and will have been scheduled for a surgical hernia repair. This surgery will be an open surgical procedure and reinforcing your tissue with material is indicated for this type of hernia repair.

Detailed description

Prior to their scheduled surgery, the patient will be consented and will complete a brief quality of life survey. They will also be asked some questions about their medical history that pertain to the study, such as current/ past abdominal infections and surgeries, history of the hernia, comorbidities, etc. During the surgery, some key data points will be recorded by the research coordinator, such as time of surgery, type of case, size of mesh used, size of the hernia defect, technique used, type of sutures used, etc. The mesh will be placed either retrorectus or intraperitoneally, after the component separation is complete. The mesh will not be used as a bridge, and the fascial layers will be closed completely. The research staff may photograph the repair of an enrolled patient's hernia during their treatment and will supply a copy of the photograph to Cook Medical, Inc. if the sponsor's review is requested. Any photograph taken for research purposes will be kept in a password-protected, encrypted database separate from any patient identifying information.

Interventions

DEVICEHernia graft/mesh

observational group

Sponsors

Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing a ventral incisional hernia repair with mesh * Age range between 18 and 80 years old

Exclusion criteria

* Patients currently enrolled in a clinical trial. * Patients with a BMI over 40 * Patients in whom the fascial layers cannot be closed or in whom bridging would be used * Patients with a current abdominal abscess or infection * Patients with healing disorders * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Hernia Recurrenceup to 2 yearsAssessment of efficacy of the device and repair

Secondary

MeasureTime frameDescription
Infectionsup to 2 yearsInfections related to the surgical site or implantation of the device
Seromasup to 2 years
Rehospitalizationup to 2 years
Re-operationup to 2 years
Mesh Removalup to 2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026